John Greene's Net Worth

$24.2 Million

Estimate Recalculated May 13, 2024 06:02PM EST

Who is John Greene?

John Greene has an estimated net worth of $24.2 Million. This is based on reported shares across multiple companies, which include Discover Financial Services, WILLIS TOWERS WATSON PLC, CRISPR Therapeutics AG, and Bioverativ Inc..

SEC CIK

John Greene's CIK is 0001610732

Past Insider Trading and Trends

2017 was John Greene's most active year for acquiring shares with 5 total transactions. John Greene's most active month to acquire stocks was the month of January. 2018 was John Greene's most active year for disposing of shares, totalling 7 transactions. John Greene's most active month to dispose stocks was the month of January. 2020 saw John Greene paying a total of $249,342.82 for 29,575 shares, this is the most they've acquired in one year. In 2024 John Greene cashed out on 59,771 shares for a total of $6,367,438.21, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Discover Financial Services (DFS) Snapshot price: $106.17

EVP, Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+136.55%
38.38K
—
—
66.48K
Feb 22
Form 4
+51.16%
9.51K
$106.56
-$1,309,622.40
28.1K
Feb 1
Form 4
+51.16%
9.51K
$106.56
-$1,309,622.40
28.1K
Feb 1
Form 4
-65.43%
-35.19K
$106.51
-$3,748,193.41
18.59K
Jan 26
Form 4
+22.86%
9.96K
—
—
53.54K
Feb 23
Form 4
+34.23%
11.11K
$115.83
-$1,631,233.89
43.58K
Feb 1
Form 4
-5.15%
-1.75K
$102.22
-$179,089.44
32.28K
Aug 1
Form 4
+27.58%
7.34K
—
—
33.95K
Feb 25
Form 4
-14.31%
-4.44K
$127.95
-$568,464.08
26.61K
Feb 15
Form 4
-6.27%
-2.08K
$118.02
-$245,363.58
31.06K
Feb 1
Form 4
-5.02%
-1.75K
$124.32
-$217,808.64
33.13K
Aug 1
Form 4
-21.74%
-9.69K
—
—
34.89K
Feb 19
Form 4
-4.35%
-1.15K
$82.19
-$94,189.74
25.2K
Feb 1
Form 4
-4.21%
-1.16K
$49.43
-$57,289.37
26.34K
Aug 1
Form 4
+14.00%
3.38K
$73.84
$249,342.82
27.5K
Jan 27
Form 4
+86.62%
11.2K
—
—
24.13K
Jan 22
Form 4
+1,112.66%
11.86K
—
—
12.93K
Sep 18
Form 3
—
0
—
—
0
No matching records found

WILLIS TOWERS WATSON PLC (WTW) Snapshot price: $270.67

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+35.93%
3.91K
—
—
14.8K
Jan 4
Form 4
+101.28%
14.52K
$44.14
-$35,488.56
28.86K
Nov 9
Form 4
+56.63%
5.18K
—
—
14.34K
Dec 16
Form 4
∞
9.15K
—
—
9.15K
Aug 11
Form 3
—
0
—
—
0
No matching records found

CRISPR Therapeutics AG (CRSP) Snapshot price: $65.965

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 11
Form 3
—
0
—
—
0
No matching records found

Bioverativ Inc. No price found

EVP, CFO and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-5.95K
—
—
0
Mar 8
Form 4
+999.09%
5K
$103.52
-$219,255.36
5.5K
Feb 14
Form 4
—
0
—
—
0
Jan 31
Form 4/A
—
0
—
—
0
Feb 14
Form 4
—
0
—
—
0
Feb 14
Form 3
—
0
—
—
0
No matching records found